Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)

This study is currently recruiting participants.
Verified July 2011 by Ann & Robert H Lurie Children's Hospital of Chicago
Sponsor:
Information provided by:
Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT01197079
First received: September 8, 2010
Last updated: July 14, 2011
Last verified: July 2011

September 8, 2010
July 14, 2011
August 2010
August 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01197079 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)
Survey Study of the Awareness, Acceptance, and Barriers to Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)

The objectives of this study are:

  1. to determine the degree of understanding and perceived risks for human papillomavirus (HPV) disease, to examine and assess attitudes for personal use of HPV vaccine and identify potential barriers to HPV vaccine access and utilization in a population of young men who have sex with men (MSM) (under 26 years of age)and in parents of boys aged 9 to 18 years
  2. to determine HPV vaccine acceptance and predictors of acceptance in a population of young MSM and in patients of boys ages 9 to 18 years
  3. to develop strategies to overcome potential barriers to vaccination and improve vaccine access and utilization via development of targeted educational initiatives.
Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Young men who have sex with men (MSM) that obtain medical care from a Gay/Lesbian/Bisexual/Transgender community health clinic

Parents of boys aged 9 to 18 years who obtain their medical care from several public health clinics or who obtain their medical care from private pediatrician offices in Chicago

Human Papillomavirus (HPV)
Other: Survey
Self administered anonymous survey
  • MSM
    Young men (under 26 years of age) who have sex with men
    Intervention: Other: Survey
  • Parents
    Parents of Boys aged 9 to 18 years
    Intervention: Other: Survey
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
800
August 2011
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • MSM group - under age 26 years
  • Parent group - parent of boy(s) ages 9 to 18 years

Exclusion Criteria:

  • MSM group - previous receipt of HPV vaccine
  • Parent group - previous receipt of HPV vaccine by male child
Male
9 Years to 26 Years
Yes
Contact: Tina Q Tan, MD 773-880-4187 ttan@northwestern.edu
Contact: Melvin V Gerbie, MD 312-951-0687 mpgerbs@aol.com
United States
 
NCT01197079
Merck IISP 37875
No
Tina Q. Tan, M.D., Children's Memorial Hospital
Ann & Robert H Lurie Children's Hospital of Chicago
Not Provided
Not Provided
Ann & Robert H Lurie Children's Hospital of Chicago
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP